Product Name | MF | CAS | Details |
---|
Antiparasitic agent-5 | C20H16ClN3O3 | 2494276-55-8 | Details |
(S)-Cdc7-IN-18 | C19H21N5OS | 2562329-13-7 | Details |
HSV-1/HSV-2-IN-2 | C17H14ClFN4OS | 2490468-39-6 | Details |
HPK1-IN-18 | C24H24N4 | 2403598-42-3 | Details |
Gü1303 | C20H22N4O3 | 1043922-53-7 | Details |
AM-1488 | C19H17N3O4S | 2079895-60-4 | Details |
ASIC-IN-1 | C23H25N3O2 | 308088-10-0 | Details |
SARS-CoV-2-IN-17 | C19H19F3N2O3 | 2761911-44-6 | Details |
CXCR4 antagonist 6 | C21H30N6 | 2304750-68-1 | Details |
ATP synthase inhibitor 2 | C21H22N2O3S | 2814540-76-4 | Details |
A1AR antagonist 4 | C23H25N3O2 | 1031993-35-7 | Details |
BuChE-IN-6 | C21H26N4O2 | 2003213-07-6 | Details |
Tubulin polymerization-IN-10 | C18H21NO6S | 2238784-19-3 | Details |
ATG7-IN-2 | C11H16N6O7S | 2226227-75-2 | Details |
CXCR4 antagonist 9 | C21H27FN6 | 2304750-83-0 | Details |
EGFR-IN-52 | C19H18N4O3S | 454436-75-0 | Details |
Myt1-IN-2 | C18H16N6O2S | 2719748-43-1 | Details |
S07-2010 | C19H21N3O3S | 1223194-71-5 | Details |
Autophagy inducer 3 | C24H43NO2 | 2691054-63-2 | Details |
S07-2005 (racemic) | C20H23NO6 | 1826337-40-9 | Details |
Antitubercular agent-24 | C18H19N3O2S2 | 1845719-43-8 | Details |
ANO1-IN-2 | C16H14ClN3O2S2 | 637314-12-6 | Details |
NMDA receptor antagonist 5 | C19H16BrNO2 | 2415998-36-4 | Details |
Tyrosinase-IN-5 | C18H13N3O6 | 2525175-90-8 | Details |
Polyketide synthase 13-IN-2 | C22H21NO5 | 2219338-48-2 | Details |
Antifungal agent 32 | C25H28N2O | 1809167-48-3 | Details |
5-HT2A receptor agonist-2 | C20H21ClN2O3 | 528525-37-3 | Details |
Anticancer agent 57 | C20H21Cl2NO2 | 2408017-71-8 | Details |
RBM10-8 | C17H36NO5P | 2407372-42-1 | Details |
ATR-IN-19 | C18H19N7OS | 2648989-61-9 | Details |
ASK1-IN-3 | C18H18N8O2 | 2426705-19-1 | Details |
Trk-IN-20 | C22H18F2N4 | 2460924-63-2 | Details |
Mt KARI-IN-4 | C13H8FN5O3S2 | 2413974-53-3 | Details |
TYK2-IN-11 | C18H17N5O3S | 2757009-40-6 | Details |
SK3 Channel-IN-1 | C25H49NO | 2396571-04-1 | Details |
SARS-CoV-2-IN-20 | C24H30N2O2 | 1260244-33-4 | Details |
Nampt-IN-7 | C20H21N5O3 | 1223378-42-4 | Details |
Z164597606 | C20H19N3O4 | 1050587-57-9 | Details |
Anti-inflammatory agent 8 | C18H15N5OS2 | 1103920-19-9 | Details |
NHE3-IN-3 | C16H16Cl2N2O2S | 543734-50-5 | Details |
EV-A71-IN-1 | C21H15N5S | 2413648-96-9 | Details |
11β-HSD1-IN-6 | C21H19ClN4O | 1303515-33-4 | Details |
LSD1-IN-14 | C21H24FN5 | 2698340-11-1 | Details |
DMX-129 | C19H17FN8 | 1623123-95-4 | Details |
5-HT7 receptor ligand 1 | C21H23N7 | 2758571-64-9 | Details |
Anti-inflammatory agent 22 | C22H16O6 | 2721484-76-8 | Details |
DHFR-IN-4 | C18H21N5O2S | 2820126-49-4 | Details |
GLP-1R modulator C5 | C24H21NO3 | 421578-93-0 | Details |
Aldose reductase-IN-6 | C20H16N4O2S | 2470019-41-9 | Details |
EGFR-IN-51 | C21H15N3O2S | 2418549-32-1 | Details |
Antileishmanial agent-9 | C23H26O4 | 2477608-91-4 | Details |
Neuraminidase-IN-5 | C19H11NO7 | 2473524-63-7 | Details |
Tubulin polymerization-IN-13 | C20H21NO6 | 2426665-56-5 | Details |
c-ABL-IN-3 | C17H11F3N4O3 | 2626934-64-1 | Details |
KDM5B-IN-3 | C19H25ClN4O2 | 1385101-10-9 | Details |
ATR-IN-16 | C19H25N7O | 2756589-62-3 | Details |
DPP-4 inhibitor 3 | C19H22N6O2 | 2402735-14-0 | Details |
Antibacterial agent 106 | C20H24N6S | 2459657-11-3 | Details |
Anticancer agent 37 | C19H19N3O3S | 905783-28-0 | Details |
DPP-4-IN-1 | C19H19ClN6 | 2215027-46-4 | Details |
Plasma kallikrein-IN-3 | C20H23N5O2 | 1357950-47-0 | Details |
CB1-IN-2 | C17H19Cl2N5O | 2527805-39-4 | Details |
Influenza A virus-IN-4 | C19H28N4O4 | 2390067-58-8 | Details |
FAK-IN-8 | C15H9Cl2N3O2S | 1374959-91-7 | Details |
TOPK-p38/JNK-IN-1 | C17H15F3N2O4 | 2745108-35-2 | Details |
DNA-PK-IN-2 | C20H23N5O3 | 2665720-22-7 | Details |
Falcipain-2/3-IN-2 | C21H23N3O4 | 946209-23-0 | Details |
ATG7-IN-3 | C11H16N6O5S2 | 2226229-76-9 | Details |
HDAC-IN-42 | C20H15NO7 | 2454024-18-9 | Details |
TP0480066 | C18H14FN3O5 | 2245693-15-4 | Details |
PKC-IN-4 | C21H25N5S | 2636771-29-2 | Details |
Tyrosinase-IN-3 | C21H23NO5 | 2409081-40-7 | Details |
CXCR4 antagonist 5 | C21H30N6 | 2304749-86-6 | Details |
3-(3-Phenoxybenzyl)amino-β-carboline | C24H19N3O | 1327080-54-5 | Details |
NPR-C activator 1 | C18H24N6O3 | 2768328-61-4 | Details |
Antitumor agent-38 | C22H24N2O4 | 2744193-34-6 | Details |
Tubulin/HDAC-IN-1 | C21H18N4O3 | 2413587-26-3 | Details |
PPARγ agonist 3 | C24H23N3O | 2011801-48-0 | Details |
FGFR-IN-7 | C16H21ClF2N4O2 | 2488764-17-4 | Details |
VPC-13789 | C21H16F3N3O | 2761146-51-2 | Details |
CSF1R-IN-13 | C21H20N4O3 | 2361556-61-6 | Details |
AChE/BChE-IN-9 | C20H19N3O4 | 2761542-55-4 | Details |
Mt KARI-IN-2 | C14H11N5O4S2 | 2413974-52-2 | Details |
VEGFR-2-IN-23 | C22H15N5O2 | 2411174-53-1 | Details |
PPARγ agonist 7 | C20H30O6 | 2569295-93-6 | Details |
ATR-IN-15 | C19H22N8O | 2756665-52-6 | Details |
AAK1-IN-4 | C20H28N4O3 | 1815612-79-3 | Details |
Antitumor agent-53 | C24H18FN3O | 2757145-67-6 | Details |
Cdc7-IN-18 | C19H21N5OS | 2562329-14-8 | Details |
HIF-2α-IN-5 | C15H12F4O3S2 | 2388500-66-9 | Details |
hCAI/II-IN-4 | C15H15N3O5S2 | 2480284-01-1 | Details |
HBV-IN-21 | C17H17FN4OS2 | 2460957-52-0 | Details |
Anticancer agent 47 | C19H14N2O4S | 2461795-23-1 | Details |
ERK5-IN-4 | C16H11Cl2FN4O2 | 1888305-17-6 | Details |
TNIK-IN-4 | C20H16FN3O3 | 2754266-04-9 | Details |
TGFβ-IN-2 | C22H22N2O4 | 2387678-02-4 | Details |
S1P1 agonist 4 | C24H31NO3 | 1883345-11-6 | Details |
NSC381467 | C20H16O7 | 1033006-96-0 | Details |
IMMH001 | C23H28N2O3 | 1418093-75-0 | Details |
PKM2 activator 3 | C15H11ClF2N2O3S | 1346113-84-5 | Details |
Product Total: Product Page: | ||||
106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 |